Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GeoVax Labs (GOVX) Free Cash Flow (2016 - 2025)

GeoVax Labs' Free Cash Flow history spans 16 years, with the latest figure at -$5.0 million for Q4 2025.

  • Quarterly results put Free Cash Flow at -$5.0 million for Q4 2025, up 36.01% from a year ago — trailing twelve months through Dec 2025 was -$21.5 million (up 12.94% YoY), and the annual figure for FY2025 was -$21.5 million, up 12.94%.
  • Free Cash Flow for Q4 2025 was -$5.0 million at GeoVax Labs, up from -$6.2 million in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of -$1.3 million in Q2 2021 to a low of -$10.3 million in Q4 2023.
  • The 5-year median for Free Cash Flow is -$5.0 million (2023), against an average of -$5.1 million.
  • The sharpest move saw Free Cash Flow crashed 481.76% in 2021, then surged 67.97% in 2024.
  • Year by year, Free Cash Flow stood at -$6.7 million in 2021, then dropped by 5.7% to -$7.1 million in 2022, then tumbled by 45.76% to -$10.3 million in 2023, then rose by 24.7% to -$7.8 million in 2024, then soared by 36.01% to -$5.0 million in 2025.
  • According to Business Quant data, Free Cash Flow over the past three periods came in at -$5.0 million, -$6.2 million, and -$4.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.